Skip to main content
MyPeptideMatch logoMyPeptideMatch
The Journal

Peptide Therapy Insights

Evidence-based guides, regulatory updates, and expert perspectives on peptide therapy. Stay informed with the latest research and clinical insights.

More in Guides

CJC-1295 / Ipamorelin Dosing: What Clinics Prescribe and What to Expect
Guides

CJC-1295 / Ipamorelin Dosing: What Clinics Prescribe and What to Expect

Explore the dosing protocols and clinical considerations for CJC-1295 / Ipamorelin, a growth hormone secretagogue used in anti-aging and recovery treatments.

Read article
PT-141 Dosing: What Clinics Prescribe and What to Expect
Guides

PT-141 Dosing: What Clinics Prescribe and What to Expect

Explore the dosing protocols for PT-141, an FDA-approved peptide for hypoactive sexual desire disorder, including titration schedules and administration methods.

Read article
Tirzepatide Results: What to Realistically Expect
Guides

Tirzepatide Results: What to Realistically Expect

Explore the realistic expectations and clinical outcomes associated with Tirzepatide therapy for weight loss and type 2 diabetes management.

Read article
Sermorelin Results: What to Realistically Expect
Guides

Sermorelin Results: What to Realistically Expect

Explore the realistic expectations and timelines for results with Sermorelin therapy. Understand clinical data, influencing factors, and how Sermorelin compares to alternatives.

Read article
CJC-1295 / Ipamorelin Results: What to Realistically Expect
Guides

CJC-1295 / Ipamorelin Results: What to Realistically Expect

Explore realistic expectations for CJC-1295 / Ipamorelin therapy, including timelines, outcomes, and factors influencing results.

Read article
PT-141 Results: What to Realistically Expect
Guides

PT-141 Results: What to Realistically Expect

Explore realistic outcomes and expectations for PT-141 peptide therapy, backed by clinical data and expert insights.

Read article
GHK-Cu Results: What to Realistically Expect
Guides

GHK-Cu Results: What to Realistically Expect

Explore realistic expectations and outcomes for GHK-Cu peptide therapy, based on clinical data and patient experiences.

Read article
Semaglutide: 15 Questions Answered by Experts
Guides

Semaglutide: 15 Questions Answered by Experts

Get answers to the most common questions about semaglutide, an FDA-approved GLP-1 receptor agonist used for weight loss and type 2 diabetes.

Read article
Acetyl Hexapeptide-3 (Argireline) Dosing: What Clinics Prescribe and What to Expect
Guides

Acetyl Hexapeptide-3 (Argireline) Dosing: What Clinics Prescribe and What to Expect

Explore the dosing protocols, administration methods, and clinical considerations for Acetyl Hexapeptide-3 (Argireline), a peptide used in cosmetic applications.

Read article

Stay Up to Date

New articles on peptide therapy, FDA regulations, and clinic reviews are published regularly. Bookmark this page or check back often.